Last checked at 11 Mar 2022 18:11
Hikma Pharmaceuticals PLC
Share Buyback Programme
London, 11 March 2022
Hikma Pharmaceuticals PLC ("Hikma") announces today that it has purchased the following number of its ordinary shares on the London Stock Exchange and/or on BATS and/or on Chi-X trading venues from Citigroup Global Markets Limited ("Citi"). The repurchased shares will be cancelled.
London Stock Exchange | BATS Trading Venue | Chi-X Trading Venue | |
Number of ordinary shares purchased: | 10,599 | 6,418 | - |
Highest price paid (per ordinary share): | £19.8300 | £19.8300 | - |
Lowest price paid (per ordinary share): | £19.7950 | £19.7950 | - |
Volume weighted average price paid (per ordinary share): | £19.8183 | £19.8169 | - |
Such purchases form part of Hikma's share buyback programme announced on 24 February 2022.
Following the settlement of the above purchases and cancellation of the purchased ordinary shares, the total number of ordinary shares in issue shall be 243,701,581 ordinary shares and the total number of ordinary shares held in treasury is 12,833,233 ordinary shares. Therefore, following the above purchases total voting rights are 230,868,348 ordinary shares.
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), the detailed breakdown of individual trades made by Citi on behalf of Hikma as part of the buyback programme is set out below.
This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.
Schedule of Purchases - Individual Transactions
Date of Transaction | Time of Transaction | Number of Shares | Price Per Share (GBp) | Trading Venue | Transaction Reference Number |
11/03/2022 | 16:13:17 | 140 | 1,980.00 | BATE | xsqArH2G6TD |
11/03/2022 | 16:12:37 | 175 | 1,979.50 | XLON | xsqArH2G7nC |
11/03/2022 | 16:12:31 | 43 | 1,980.00 | XLON | xsqArH2G7@e |
11/03/2022 | 16:12:31 | 103 | 1,980.00 | XLON | xsqArH2G7@g |
11/03/2022 | 16:12:31 | 138 | 1,980.00 | BATE | xsqArH2G7@i |
11/03/2022 | 16:12:02 | 135 | 1,980.00 | XLON | xsqArH2G7BH |
11/03/2022 | 16:11:52 | 46 | 1,980.50 | XLON | xsqArH2G7I7 |
11/03/2022 | 16:11:52 | 38 | 1,980.50 | XLON | xsqArH2G7I9 |
11/03/2022 | 16:11:52 | 97 | 1,980.50 | BATE | xsqArH2G7IB |
11/03/2022 | 16:11:43 | 123 | 1,981.00 | BATE | xsqArH2G7Rh |
11/03/2022 | 16:11:43 | 112 | 1,981.00 | XLON | xsqArH2G7Rf |
11/03/2022 | 16:11:37 | 131 | 1,981.50 | BATE | xsqArH2G4dW |
11/03/2022 | 16:11:37 | 84 | 1,981.50 | XLON | xsqArH2G4aS |
11/03/2022 | 16:11:37 | 35 | 1,981.50 | XLON | xsqArH2G4aU |
11/03/2022 | 16:11:28 | 19 | 1,982.00 | XLON | xsqArH2G4jH |
11/03/2022 | 16:11:28 | 117 | 1,982.00 | BATE | xsqArH2G4jL |
11/03/2022 | 16:11:28 | 127 | 1,982.00 | XLON | xsqArH2G4jJ |
11/03/2022 | 16:10:35 | 28 | 1,982.00 | BATE | xsqArH2G4BU |
11/03/2022 | 16:10:35 | 18 | 1,982.00 | BATE | xsqArH2G4AW |
11/03/2022 | 16:10:35 | 75 | 1,982.00 | BATE | xsqArH2G4AY |
11/03/2022 | 16:10:22 | 54 | 1,983.00 | XLON | xsqArH2G4IL |
11/03/2022 | 16:07:35 | 117 | 1,982.50 | BATE | xsqArH2G2K8 |
11/03/2022 | 16:07:32 | 72 | 1,983.00 | XLON | xsqArH2G2NT |
11/03/2022 | 16:07:32 | 139 | 1,983.00 | BATE | xsqArH2G2MX |
11/03/2022 | 16:07:30 | 6 | 1,983.00 | BATE | xsqArH2G2GW |
11/03/2022 | 16:07:30 | 389 | 1,983.00 | BATE | xsqArH2G2GY |
11/03/2022 | 16:07:30 | 175 | 1,983.00 | XLON | xsqArH2G2Ga |
11/03/2022 | 16:07:21 | 548 | 1,983.00 | XLON | xsqArH2G2Rh |
11/03/2022 | 14:10:20 | 127 | 1,982.00 | BATE | xsqArH2I@B@ |
11/03/2022 | 14:08:41 | 51 | 1,982.00 | BATE | xsqArH2I$Me |
11/03/2022 | 14:08:41 | 13 | 1,982.00 | BATE | xsqArH2I$Mi |
11/03/2022 | 14:08:41 | 94 | 1,982.00 | XLON | xsqArH2I$Mg |
11/03/2022 | 14:08:41 | 202 | 1,982.50 | XLON | xsqArH2I$Mk |
11/03/2022 | 14:08:41 | 68 | 1,982.50 | BATE | xsqArH2I$Mm |
11/03/2022 | 14:08:41 | 30 | 1,982.50 | BATE | xsqArH2I$Mo |
11/03/2022 | 14:08:41 | 206 | 1,983.00 | BATE | xsqArH2I$Mw |
11/03/2022 | 14:08:41 | 15 | 1,983.00 | BATE | xsqArH2I$M@ |
11/03/2022 | 14:08:41 | 493 | 1,983.00 | XLON | xsqArH2I$Mu |
11/03/2022 | 13:55:34 | 75 | 1,983.00 | XLON | xsqArH2IcQm |
11/03/2022 | 13:54:48 | 135 | 1,983.00 | XLON | xsqArH2Idum |
11/03/2022 | 13:52:46 | 54 | 1,983.00 | BATE | xsqArH2Iam6 |
11/03/2022 | 13:49:29 | 2 | 1,983.00 | BATE | xsqArH2IYXe |
11/03/2022 | 13:49:29 | 21 | 1,983.00 | BATE | xsqArH2IYXg |
11/03/2022 | 13:49:29 | 63 | 1,983.00 | BATE | xsqArH2IYXi |
11/03/2022 | 13:01:40 | 102 | 1,983.00 | XLON | xsqArH2IRT6 |
11/03/2022 | 13:01:40 | 6 | 1,983.00 | BATE | xsqArH2IRT8 |
11/03/2022 | 13:01:40 | 116 | 1,983.00 | BATE | xsqArH2IRTA |
11/03/2022 | 11:37:39 | 96 | 1,983.00 | XLON | xsqArH2JZ29 |
11/03/2022 | 11:23:16 | 108 | 1,980.50 | XLON | xsqArH2JMyx |
11/03/2022 | 11:23:16 | 53 | 1,981.00 | XLON | xsqArH2JMy8 |
11/03/2022 | 11:23:16 | 73 | 1,981.00 | XLON | xsqArH2JMyA |
11/03/2022 | 11:23:11 | 190 | 1,981.50 | XLON | xsqArH2JM@S |
11/03/2022 | 11:23:11 | 36 | 1,982.00 | XLON | xsqArH2JMvW |
11/03/2022 | 11:23:11 | 400 | 1,982.00 | XLON | xsqArH2JMvY |
11/03/2022 | 11:20:15 | 120 | 1,982.50 | BATE | xsqArH2JN43 |
11/03/2022 | 11:20:15 | 117 | 1,982.50 | XLON | xsqArH2JN4z |
11/03/2022 | 11:20:15 | 139 | 1,982.50 | XLON | xsqArH2JN4$ |
11/03/2022 | 11:19:09 | 167 | 1,982.50 | XLON | xsqArH2JNTW |
11/03/2022 | 11:18:54 | 279 | 1,983.00 | XLON | xsqArH2JNO4 |
11/03/2022 | 11:18:54 | 173 | 1,983.00 | BATE | xsqArH2JNO6 |
11/03/2022 | 11:14:32 | 102 | 1,983.00 | BATE | xsqArH2JL6U |
11/03/2022 | 11:12:19 | 10 | 1,982.50 | XLON | xsqArH2JIzZ |
11/03/2022 | 11:12:19 | 54 | 1,982.50 | XLON | xsqArH2JIzf |
11/03/2022 | 11:12:19 | 12 | 1,982.50 | XLON | xsqArH2JIzh |
11/03/2022 | 11:12:19 | 40 | 1,982.50 | XLON | xsqArH2JIzo |
11/03/2022 | 11:12:19 | 154 | 1,982.50 | XLON | xsqArH2JIzq |
11/03/2022 | 11:12:19 | 138 | 1,982.00 | XLON | xsqArH2JIz3 |
11/03/2022 | 11:12:09 | 59 | 1,980.00 | XLON | xsqArH2JIuX |
11/03/2022 | 11:11:41 | 154 | 1,980.00 | BATE | xsqArH2JIM9 |
11/03/2022 | 11:11:01 | 3 | 1,980.50 | BATE | xsqArH2JJfs |
11/03/2022 | 11:10:58 | 306 | 1,981.50 | BATE | xsqArH2JJhY |
11/03/2022 | 11:10:58 | 16 | 1,981.50 | BATE | xsqArH2JJha |
11/03/2022 | 11:10:56 | 95 | 1,981.50 | BATE | xsqArH2JJgH |
11/03/2022 | 11:10:56 | 68 | 1,981.50 | BATE | xsqArH2JJgJ |
11/03/2022 | 11:10:56 | 100 | 1,980.50 | BATE | xsqArH2JJgT |
11/03/2022 | 11:10:56 | 40 | 1,981.50 | BATE | xsqArH2JJr@ |
11/03/2022 | 11:10:56 | 119 | 1,980.50 | XLON | xsqArH2JJr9 |
11/03/2022 | 11:10:56 | 80 | 1,981.00 | XLON | xsqArH2JJrJ |
11/03/2022 | 11:10:56 | 194 | 1,981.00 | XLON | xsqArH2JJrL |
11/03/2022 | 11:10:56 | 6 | 1,981.00 | BATE | xsqArH2JJrN |
11/03/2022 | 11:10:56 | 96 | 1,981.00 | BATE | xsqArH2JJrP |
11/03/2022 | 11:09:43 | 19 | 1,981.50 | BATE | xsqArH2JJN0 |
11/03/2022 | 11:09:24 | 21 | 1,980.00 | BATE | xsqArH2JJQr |
11/03/2022 | 11:09:24 | 157 | 1,980.00 | XLON | xsqArH2JJQs |
11/03/2022 | 11:09:24 | 119 | 1,979.50 | XLON | xsqArH2JJQ9 |
11/03/2022 | 11:09:24 | 24 | 1,979.50 | BATE | xsqArH2JJQB |
11/03/2022 | 11:09:24 | 38 | 1,979.50 | BATE | xsqArH2JJQD |
11/03/2022 | 11:09:24 | 108 | 1,980.00 | BATE | xsqArH2JJQH |
11/03/2022 | 11:09:24 | 85 | 1,980.00 | XLON | xsqArH2JJQF |
11/03/2022 | 11:09:24 | 189 | 1,980.00 | XLON | xsqArH2JJQJ |
11/03/2022 | 11:08:04 | 131 | 1,980.50 | XLON | xsqArH2JG2K |
11/03/2022 | 11:05:45 | 55 | 1,980.50 | XLON | xsqArH2JH7Y |
11/03/2022 | 11:05:45 | 158 | 1,980.50 | XLON | xsqArH2JH7y |
11/03/2022 | 11:05:36 | 38 | 1,980.50 | XLON | xsqArH2JH0f |
11/03/2022 | 11:05:36 | 51 | 1,980.00 | XLON | xsqArH2JH0t |
11/03/2022 | 11:04:38 | 5 | 1,980.00 | BATE | xsqArH2JHSH |
11/03/2022 | 11:04:38 | 200 | 1,980.00 | BATE | xsqArH2JHSJ |
11/03/2022 | 11:04:38 | 25 | 1,980.00 | BATE | xsqArH2JHSL |
11/03/2022 | 11:04:38 | 33 | 1,980.00 | BATE | xsqArH2JHSP |
11/03/2022 | 11:03:42 | 68 | 1,979.50 | XLON | xsqArH2JUey |
11/03/2022 | 11:03:42 | 119 | 1,980.00 | XLON | xsqArH2JUe0 |
11/03/2022 | 11:03:39 | 53 | 1,980.50 | XLON | xsqArH2JUhB |
11/03/2022 | 11:03:39 | 200 | 1,980.50 | XLON | xsqArH2JUhD |
11/03/2022 | 11:03:39 | 21 | 1,980.50 | XLON | xsqArH2JUhF |
11/03/2022 | 11:03:39 | 88 | 1,981.00 | BATE | xsqArH2JUhJ |
11/03/2022 | 11:03:39 | 149 | 1,981.50 | BATE | xsqArH2JUhH |
11/03/2022 | 11:03:38 | 224 | 1,983.00 | XLON | xsqArH2JUgo |
11/03/2022 | 11:03:38 | 63 | 1,983.00 | XLON | xsqArH2JUgq |
11/03/2022 | 11:03:38 | 32 | 1,983.00 | XLON | xsqArH2JUgs |
11/03/2022 | 11:03:38 | 192 | 1,983.00 | XLON | xsqArH2JUg$ |
11/03/2022 | 11:03:37 | 195 | 1,983.00 | XLON | xsqArH2JUg5 |
11/03/2022 | 11:03:37 | 1 | 1,983.00 | XLON | xsqArH2JUgB |
11/03/2022 | 11:03:37 | 130 | 1,983.00 | XLON | xsqArH2JUgD |
11/03/2022 | 11:03:37 | 32 | 1,983.00 | XLON | xsqArH2JUgF |
11/03/2022 | 11:03:37 | 145 | 1,983.00 | XLON | xsqArH2JUrh |
11/03/2022 | 11:03:37 | 32 | 1,983.00 | XLON | xsqArH2JUrj |
11/03/2022 | 11:03:37 | 62 | 1,983.00 | XLON | xsqArH2JUrs |
11/03/2022 | 11:03:37 | 13 | 1,983.00 | XLON | xsqArH2JUr3 |
11/03/2022 | 11:03:37 | 102 | 1,983.00 | XLON | xsqArH2JUr5 |
11/03/2022 | 11:03:37 | 84 | 1,980.50 | BATE | xsqArH2JUrU |
11/03/2022 | 11:03:37 | 112 | 1,980.50 | BATE | xsqArH2JUqa |
11/03/2022 | 11:03:37 | 274 | 1,980.50 | XLON | xsqArH2JUqi |
11/03/2022 | 11:02:35 | 50 | 1,981.50 | BATE | xsqArH2JUMv |
11/03/2022 | 11:02:35 | 61 | 1,981.50 | BATE | xsqArH2JUMJ |
11/03/2022 | 11:02:35 | 50 | 1,981.50 | BATE | xsqArH2JUH3 |
11/03/2022 | 11:02:35 | 259 | 1,981.50 | BATE | xsqArH2JUHL |
11/03/2022 | 11:02:22 | 4 | 1,981.50 | BATE | xsqArH2JUON |
11/03/2022 | 11:02:22 | 7 | 1,981.50 | BATE | xsqArH2JUOP |
11/03/2022 | 11:02:01 | 45 | 1,981.50 | BATE | xsqArH2JVWt |
11/03/2022 | 11:02:01 | 273 | 1,981.00 | XLON | xsqArH2JVW2 |
11/03/2022 | 11:02:01 | 99 | 1,981.00 | BATE | xsqArH2JVW8 |
11/03/2022 | 10:59:54 | 102 | 1,981.50 | BATE | xsqArH2JSdf |
11/03/2022 | 10:58:51 | 103 | 1,981.00 | BATE | xsqArH2JS7J |
11/03/2022 | 10:58:51 | 60 | 1,981.00 | BATE | xsqArH2JS7L |
11/03/2022 | 10:58:51 | 118 | 1,980.00 | XLON | xsqArH2JS6g |
11/03/2022 | 10:58:51 | 50 | 1,980.00 | BATE | xsqArH2JS6e |
11/03/2022 | 10:58:51 | 18 | 1,980.00 | BATE | xsqArH2JS6i |
11/03/2022 | 10:58:51 | 152 | 1,980.50 | XLON | xsqArH2JS6m |
11/03/2022 | 10:58:51 | 46 | 1,980.50 | XLON | xsqArH2JS6o |
11/03/2022 | 10:58:51 | 75 | 1,980.50 | XLON | xsqArH2JS6q |
11/03/2022 | 10:58:51 | 4 | 1,980.50 | BATE | xsqArH2JS6y |
11/03/2022 | 10:58:51 | 98 | 1,980.50 | BATE | xsqArH2JS6@ |
11/03/2022 | 10:55:08 | 67 | 1,981.50 | XLON | xsqArH2JQ@M |
11/03/2022 | 10:55:08 | 102 | 1,982.00 | XLON | xsqArH2JQ@R |
11/03/2022 | 10:54:46 | 42 | 1,982.00 | XLON | xsqArH2JQCu |
11/03/2022 | 10:54:46 | 183 | 1,982.50 | XLON | xsqArH2JQFw |
11/03/2022 | 10:54:46 | 125 | 1,983.00 | BATE | xsqArH2JQF@ |
11/03/2022 | 10:54:46 | 422 | 1,983.00 | XLON | xsqArH2JQFy |
11/03/2022 | 10:27:24 | 64 | 1,983.00 | BATE | xsqArH2JEPx |
11/03/2022 | 10:27:24 | 51 | 1,983.00 | BATE | xsqArH2JEPz |
11/03/2022 | 10:27:12 | 100 | 1,983.00 | BATE | xsqArH2JFdI |
11/03/2022 | 10:27:12 | 99 | 1,983.00 | BATE | xsqArH2JFcX |
11/03/2022 | 10:18:20 | 59 | 1,980.50 | XLON | xsqArH2JBtm |
11/03/2022 | 10:18:20 | 71 | 1,980.50 | BATE | xsqArH2JBto |
11/03/2022 | 10:18:18 | 2 | 1,981.00 | XLON | xsqArH2JBtR |
11/03/2022 | 10:18:18 | 76 | 1,981.00 | XLON | xsqArH2JBtT |
11/03/2022 | 10:18:18 | 78 | 1,981.00 | BATE | xsqArH2JBtV |
11/03/2022 | 10:18:14 | 104 | 1,982.50 | BATE | xsqArH2JBme |
11/03/2022 | 10:17:40 | 4 | 1,982.00 | XLON | xsqArH2JB7Q |
11/03/2022 | 10:17:40 | 98 | 1,982.00 | XLON | xsqArH2JB7S |
11/03/2022 | 10:17:40 | 167 | 1,982.50 | XLON | xsqArH2JB7U |
11/03/2022 | 10:17:40 | 98 | 1,982.50 | BATE | xsqArH2JB6Y |
11/03/2022 | 10:17:40 | 35 | 1,983.00 | BATE | xsqArH2JB6a |
11/03/2022 | 10:17:40 | 20 | 1,983.00 | BATE | xsqArH2JB6c |
11/03/2022 | 10:17:40 | 387 | 1,983.00 | XLON | xsqArH2JB6W |
11/03/2022 | 10:17:40 | 88 | 1,983.00 | BATE | xsqArH2JB6e |
-- ENDS --
Enquiries: |
Hikma Pharmaceuticals PLC
| |
Peter SpeirsCompany Secretary | +44 (0)20 7399 2772 |
Susan RingdalEVP Strategy and Global Affairs | +44 (0)20 7399 2760 |
About Hikma
Hikma helps put better health within reach every day for millions of people around the world. For more than 40 years, we've been creating high-quality medicines and making them accessible to the people who need them. Headquartered in the UK, we are a global company with a local presence across the United States (US), the Middle East and North Africa (MENA) and Europe, and we use our unique insight and expertise to transform cutting-edge science into innovative solutions that transform people's lives. We're committed to our customers, and the people they care for, and by thinking creatively and acting practically, we provide them with a broad range of branded and non-branded generic medicines. Together, our 8,700 colleagues are helping to shape a healthier world that enriches all our communities. We are a leading licensing partner, and through our venture capital arm, are helping bring innovative health technologies to people around the world. For more information, please visit: www.hikma.com.
(LEI:549300BNS685UXH4JI75)